search
Back to results

Evaluation of the Performance and Safety of a Medical Device Developed to Improve the Reading of Dyslexic Patients (DysLight)

Primary Purpose

Dyslexia

Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Scintilling lamp
Classic lamp
Sponsored by
SATT Ouest Valorisation
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Dyslexia focused on measuring Dyslexia, Reading disorder

Eligibility Criteria

8 Years - 11 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Schooled in CE2, CM1 or CM2,
  • French mother tongue,
  • For whom developmental dyslexia has been diagnosed by a health professional who specializes in this learning disorder,
  • Presenting an IQ ≥ 80 and ≤130 according to the WISC-V test performed by a psychologist,
  • For which a written consent was obtained regarding his study participation.

Exclusion Criteria:

  • With medical history or presenting a neurological pathology,
  • Presenting a developmental disorder (autism, ADHD, ...),
  • Presenting hearing disorders,
  • Presenting visual disorders,
  • Any other condition that, in the opinion of health professionals, could impair its ability to complete the study or could pose a significant risk.

Sites / Locations

  • Dr Laurence Derieux
  • Dr Luc-Marie Virlet
  • Dr Hugo Peyre
  • Dr Catherine ALLAIRE

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Scintilling lamp- Classic lamp

Classic lamp- Scintilling lamp

Arm Description

Outcomes

Primary Outcome Measures

Reading performance aloud of a text with french E.L.FE Test
E.L.FE Test (=Evaluation de la Lecture en FluencE) - "Monsieur Petit" and "Le Géant égoïste" texts : percentile

Secondary Outcome Measures

Reading performance aloud of isolated words with french BALE Test
BALE test (=Batterie Analytique de Langage Ecrit): percentile
Security: incidence of Adverse Events
By questioning the patient & the speech therapist - evaluation of adverse effects due to scintilling lamp (Yes/ No): headache, nausea, dizziness, fatigue and eye fatigue. Accotding to patient questioning and clinical exam, the Adverse Event Table will be completed (description, dates, severity, imputability, action,...).
Patient's satisfaction regarding reading fluency
patient interview with VAS (Visual Analogue Scale): 0 - 100 mm
Speech therapist's satisfaction regarding Securirty, Performance and usability of scintilling lamp
speech therapist interview with 4 points - Likert scale (Very good, Good, Moderate, Bad)

Full Information

First Posted
November 4, 2019
Last Updated
April 28, 2021
Sponsor
SATT Ouest Valorisation
Collaborators
Slb Pharma
search

1. Study Identification

Unique Protocol Identification Number
NCT04157829
Brief Title
Evaluation of the Performance and Safety of a Medical Device Developed to Improve the Reading of Dyslexic Patients
Acronym
DysLight
Official Title
Evaluation of the Performance and Safety of a Scintillating Lamp Developed to Improve the Reading of Dyslexic Patients
Study Type
Interventional

2. Study Status

Record Verification Date
April 2021
Overall Recruitment Status
Completed
Study Start Date
December 18, 2019 (Actual)
Primary Completion Date
January 8, 2021 (Actual)
Study Completion Date
January 8, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
SATT Ouest Valorisation
Collaborators
Slb Pharma

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The aim of this study is to evaluate the efficacy and safety of a new medical device on the improvement of reading skills of dyslexic patients.
Detailed Description
Dyslexia is defined as a specific learning disability that is characterized by reading difficulties, in the absence of intellectual disability, neurological or psychiatric disorder, uncorrected sensory disturbance (sight, hearing) or an educational deficiency. Dyslexia appears in the child from the earliest stages of learning in the form of a difficulty in mastering the learning of reading. This disorder is manifested by a generally hesitant reading, slowed down, full of errors, requiring a lot of effort for the child and may impact his reading comprehension. The dyslexia-related deficiency is of variable intensity depending on the individual; it may be accompanied by calculus disorders (dyscalculia), oral language (dysphasia), motor coordination (dyspraxia) or attention disorders with or without hyperactivity. In nearly 40% of cases, a child affected by Dys disorders presents several learning disorders. To date, the causes of dyslexia are not yet clearly established. The wide variety of symptoms and disorders associated with dyslexia does not facilitate the identification of precise neurobiological / psycho cognitive mechanisms. There are therefore several theories: phonological, visual, temporal, cerebellar or proprioceptive auditory processing. Recently, following work published in 2017, an anatomical cause based on Maxwell's spots could also be a cause of dyslexia. The aim of this study is to evaluate a new medical device to compensate this probable anatomical cause.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dyslexia
Keywords
Dyslexia, Reading disorder

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
33 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Scintilling lamp- Classic lamp
Arm Type
Experimental
Arm Title
Classic lamp- Scintilling lamp
Arm Type
Experimental
Intervention Type
Device
Intervention Name(s)
Scintilling lamp
Intervention Description
Lamp with a standardized scintilling
Intervention Type
Device
Intervention Name(s)
Classic lamp
Intervention Description
Lamp without a scintilling
Primary Outcome Measure Information:
Title
Reading performance aloud of a text with french E.L.FE Test
Description
E.L.FE Test (=Evaluation de la Lecture en FluencE) - "Monsieur Petit" and "Le Géant égoïste" texts : percentile
Time Frame
1 day
Secondary Outcome Measure Information:
Title
Reading performance aloud of isolated words with french BALE Test
Description
BALE test (=Batterie Analytique de Langage Ecrit): percentile
Time Frame
1 day
Title
Security: incidence of Adverse Events
Description
By questioning the patient & the speech therapist - evaluation of adverse effects due to scintilling lamp (Yes/ No): headache, nausea, dizziness, fatigue and eye fatigue. Accotding to patient questioning and clinical exam, the Adverse Event Table will be completed (description, dates, severity, imputability, action,...).
Time Frame
1 day
Title
Patient's satisfaction regarding reading fluency
Description
patient interview with VAS (Visual Analogue Scale): 0 - 100 mm
Time Frame
1 day
Title
Speech therapist's satisfaction regarding Securirty, Performance and usability of scintilling lamp
Description
speech therapist interview with 4 points - Likert scale (Very good, Good, Moderate, Bad)
Time Frame
1 day

10. Eligibility

Sex
All
Minimum Age & Unit of Time
8 Years
Maximum Age & Unit of Time
11 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Schooled in CE2, CM1 or CM2, French mother tongue, For whom developmental dyslexia has been diagnosed by a health professional who specializes in this learning disorder, Presenting an IQ ≥ 80 and ≤130 according to the WISC-V test performed by a psychologist, For which a written consent was obtained regarding his study participation. Exclusion Criteria: With medical history or presenting a neurological pathology, Presenting a developmental disorder (autism, ADHD, ...), Presenting hearing disorders, Presenting visual disorders, Any other condition that, in the opinion of health professionals, could impair its ability to complete the study or could pose a significant risk.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Catherine Allaire, Dr
Organizational Affiliation
CHU Rennes
Official's Role
Principal Investigator
Facility Information:
Facility Name
Dr Laurence Derieux
City
Caen
ZIP/Postal Code
14000
Country
France
Facility Name
Dr Luc-Marie Virlet
City
Faumont
ZIP/Postal Code
59310
Country
France
Facility Name
Dr Hugo Peyre
City
Paris
ZIP/Postal Code
75935
Country
France
Facility Name
Dr Catherine ALLAIRE
City
Rennes
ZIP/Postal Code
35000
Country
France

12. IPD Sharing Statement

Learn more about this trial

Evaluation of the Performance and Safety of a Medical Device Developed to Improve the Reading of Dyslexic Patients

We'll reach out to this number within 24 hrs